期刊： JHEP REPORTS, 2022; 4 (10)
Background & Aims: Pre-acute-on-chronic liver failure (ACLF) is a distinct intermediate stage between acute decompensation (AD) and ACLF. However,......
Background & Aims: Hepatic encephalopathy (HE) is a major complication after transjugular intrahepatic portosystemic shunt (TIPS) and is primarily......
期刊： JHEP REPORTS, 2022; 4 (10)
Background & Aims: Acetaminophen (APAP)-induced acute liver injury (ALI) is a global health issue characterised by an incomplete understanding of ......
Background & Aims: Accurate hepatocellular carcinoma (HCC) risk prediction facilitates appropriate surveillance strategy and reduces cancer mortal......
期刊： JHEP REPORTS, 2022; 4 (12)
Background & Aims: Among individuals with Child-Pugh B cirrhosis and acute variceal bleeding (AVB), the Baveno VII workshop recommended pre-emptiv......
期刊： JHEP REPORTS, 2022; 4 (10)
Background & Aims: HEV variants such as swine genotypes within Paslahepevirus species balayani (HEV-A) and rat HEV (Rocahepevirus ratti; HEV-C1) c......
期刊： JHEP REPORTS, 2022; 4 (11)
Background & Aims: XBP1 modulates the macrophage proinflammatory response, but its function in macrophage stimulator of interferon genes (STING) a......
期刊： JHEP REPORTS, 2022; 4 (11)
Background & Aims: Non-invasive stratification of the liver decompensation risk remains unmet in people with compen-sated cirrhosis. This study ai......
Background & Aims: HBV has a narrow host restriction, with humans and chimpanzees representing the only known natural hosts. The molecular correla......
Background & Aims: Wilson's disease (WD) is an autosomal recessive disorder of copper metabolism caused by loss-of function mutations in ATP7B, wh......
Background & Aims: We aimed to investigate how viral quasispecies of the HBV whole genome evolves and diversifies in response to HBeAg seroconvers......
Background & Aims: The albumin-bilirubin (ALBI) grade/score is derived from a validated nomogram to objectively assess prognosis and liver functio......
Background & Aims: Zinc finger and BTB domain containing 20 (ZBTB20) has been implicated as a potential oncogene in liver cancer. However, knockou......
Background & aims: Immune checkpoint blockade (ICB) has been approved for treatment of hepatocellular carcinoma (HCC). However, many patients with......
